JUSTIN OVERHOFF: Open Payments
NPI 1508331836 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,326 in 44 payments from 13 companies in 2025. Trend: 2023 $709 · 2024 $1,116 · 2025 $1,326
Food & beverage: $1,126Education: $200
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $248 |
| Boston Scientific Corporation | 5 | $243 |
| Sumitomo Pharma America, Inc. | 9 | $226 |
| Janssen Biotech, Inc. | 8 | $150 |
| Ferring Pharmaceuticals Inc. | 4 | $127 |
| ABBVIE INC. | 5 | $100 |
| BLUEWIND MEDICAL | 1 | $82 |
| ACCORD HEALTHCARE, INC. | 2 | $38 |
| IMMUNITYBIO, INC. | 2 | $34 |
| BIOPROTECT MEDICAL, INC. | 1 | $24 |
Products named: GEMTESA, AMS 700, ADSTILADRIN, ERLEADA, BOTOX, Axonics, REVI, Xtandi.
Industry payments across WA — which companies pay providers there.
